{"id":3842,"date":"2026-08-14T12:03:00","date_gmt":"2026-08-14T12:03:00","guid":{"rendered":"https:\/\/futurenews24.com\/index.php\/2026\/08\/14\/utm_campaignrss-34\/"},"modified":"2026-08-17T00:59:04","modified_gmt":"2026-08-17T00:59:04","slug":"utm_campaignrss-34","status":"publish","type":"post","link":"https:\/\/futurenews24.com\/index.php\/2026\/08\/14\/utm_campaignrss-34\/","title":{"rendered":"FDA clears Bristol a number of myeloma remedy, marking debut of latest drug class"},"content":{"rendered":"<p><br \/>\n<\/p>\n<div data-author=\"adam-feuerstein\">\n<p class=\"author-bio\">Adam Feuerstein is a senior author and biotech columnist, reporting on the crossroads of drug growth, enterprise, Wall Avenue, and biotechnology. He&#8217;s additionally a co-host of the weekly biotech podcast The Readout Loud and creator of the e-newsletter Adam\u2019s Biotech Scorecard. You possibly can attain Adam on Sign at stataf.54.<\/p>\n<\/div>\n<div>\n<p class=\"wp-block-paragraph\">The Meals and Drug Administration on Thursday authorised an oral remedy for superior a number of myeloma made by Bristol Myers Squibb, marking the debut of a brand new class of medication for the blood most cancers and the primary drug cleared by U.S. regulators utilizing a extra delicate measure of remission.\u00a0<\/p>\n<p class=\"wp-block-paragraph\">The Bristol drug, iberdomide, might be bought beneath the model title Zenbexus. It is going to be utilized in mixture with two different medicine, Darzalex and dexamethasone, to deal with sufferers with a number of myeloma who&#8217;ve acquired no less than one prior line of remedy.\u00a0<\/p>\n<p class=\"wp-block-paragraph\">\u201cWith the Zenbexus approval, Bristol is the primary firm to deliver a novel class of medicine to sufferers with a number of myeloma, opening venues for a lot of extra potential combos,\u201d mentioned Cristian Massacesi, Bristol\u2019s chief medical officer, in an interview with STAT forward of the approval announcement.\u00a0<\/p>\n<div class=\"restricted-content-breaker article\" aria-labelledby=\"restricted-story-heading\" aria-describedby=\"restricted-story-description\" checked=\"false\">\n<div class=\"restricted-content-breaker-bar\">\n<p class=\"restricted-text\">STAT+ Unique Story<\/p>\n<p class=\"restricted-login\">Have already got an account? Log in<\/p>\n<\/p><\/div>\n<p>\t\t\t<img decoding=\"async\" class=\"restricted-content-breaker-bg\" src=\"https:\/\/www.statnews.com\/wp-content\/themes\/stat\/images\/stat-plus-breaker-bg.png\" alt=\"STAT+\"\/><\/p>\n<div class=\"restricted-content-breaker-wrapper\">\n\t\t\t\t<span class=\"stat-paywall-archive\"><\/p>\n<p>\t\t\t\t\t\t<img decoding=\"async\" class=\"stat-plus-logo\" src=\"https:\/\/www.statnews.com\/wp-content\/themes\/stat\/images\/stat-plus-logo-white.svg\" alt=\"STAT+\"\/><\/p>\n<p>\t\t\t\t<\/span><\/p>\n<h2 id=\"restricted-story-heading\">This text is unique to STAT+ subscribers<\/h2>\n<h3 id=\"restricted-story-description\">Unlock this text \u2014 plus every day protection and evaluation of the biotech sector \u2014 by subscribing to STAT+.<\/h3>\n<p class=\"restricted-content-breaker-wrapper-cta mobile\">Have already got an account? Log in<\/p>\n<div class=\"restricted-content-breaker-cards\">\n<div class=\"slider-container\" aria-label=\"Subscription plan toggle\">\n\t\t\t\t\t\tParticular person plans<\/p>\n<p>\t\t\t\t\t\tGroup plans\n\t\t\t\t\t<\/p><\/div><\/div>\n<p>\t\t\t\tView All Plans\n\t\t\t<\/p><\/div><\/div>\n<div class=\"restricted-message-breaker\">\n<div class=\"restricted-content-wrapper\">\n<div class=\"restricted-content-message\">\n<p class=\"restricted-content-text\">\n\t\t\t\t\t\tTo learn the remainder of this story subscribe to STAT+.\t\t\t\t\t<\/p>\n<p>\t\t\t\t\tSubscribe\n\t\t\t\t\t\t\t\t\t<\/p><\/div><\/div><\/div><\/div>\n<p><br \/>\n<br \/><a href=\"https:\/\/www.statnews.com\/2026\/08\/14\/fda-approves-bristol-multiple-myeloma-drug-zenbexus\/?utm_campaign=rss\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Adam Feuerstein is a senior author and biotech columnist, reporting on the crossroads of drug growth, enterprise, Wall Avenue, and biotechnology. He&#8217;s additionally a co-host of the weekly biotech podcast The Readout Loud and creator of the e-newsletter Adam\u2019s Biotech Scorecard. You possibly can attain Adam on Sign at stataf.54. The Meals and Drug Administration [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":3844,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/www.statnews.com\/wp-content\/uploads\/2022\/12\/AdobeStock_251916311-1024x576.jpeg","fifu_image_alt":"","jnews-multi-image_gallery":[],"jnews_single_post":[],"jnews_primary_category":[],"jnews_override_bookmark_settings":[],"jnews_social_meta":[],"jnews_override_counter":[],"footnotes":""},"categories":[10],"tags":[4165,4169,4164,4168,497,813,4167,2422,4166,851],"class_list":["post-3842","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-biotechnology","tag-bristol","tag-class","tag-clears","tag-debut","tag-drug","tag-fda","tag-marking","tag-multiple","tag-myeloma","tag-therapy"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>FDA clears Bristol a number of myeloma remedy, marking debut of latest drug class - Future News 24<\/title>\n<meta name=\"description\" content=\"Zenbexus, from Bristol Myers Squibb, is also first drug cleared using more sensitive measure of cancer remission.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/futurenews24.com\/index.php\/2026\/08\/14\/utm_campaignrss-34\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FDA clears Bristol a number of myeloma remedy, marking debut of latest drug class - Future News 24\" \/>\n<meta property=\"og:description\" content=\"Zenbexus, from Bristol Myers Squibb, is also first drug cleared using more sensitive measure of cancer remission.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/futurenews24.com\/index.php\/2026\/08\/14\/utm_campaignrss-34\/\" \/>\n<meta property=\"og:site_name\" content=\"Future News 24\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-14T12:03:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-17T00:59:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.statnews.com\/wp-content\/uploads\/2022\/12\/AdobeStock_251916311-1024x576.jpeg\" \/>\n<meta name=\"author\" content=\"Future News 24\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.statnews.com\/wp-content\/uploads\/2022\/12\/AdobeStock_251916311-1024x576.jpeg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Future News 24\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/14\\\/utm_campaignrss-34\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/14\\\/utm_campaignrss-34\\\/\"},\"author\":{\"name\":\"Future News 24\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#\\\/schema\\\/person\\\/cecad1bde21cfc357cf70128144d6c83\"},\"headline\":\"FDA clears Bristol a number of myeloma remedy, marking debut of latest drug class\",\"datePublished\":\"2026-08-14T12:03:00+00:00\",\"dateModified\":\"2026-08-17T00:59:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/14\\\/utm_campaignrss-34\\\/\"},\"wordCount\":280,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/14\\\/utm_campaignrss-34\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.statnews.com\\\/wp-content\\\/uploads\\\/2022\\\/12\\\/AdobeStock_251916311-1024x576.jpeg\",\"keywords\":[\"Bristol\",\"class\",\"clears\",\"debut\",\"drug\",\"FDA\",\"marking\",\"Multiple\",\"myeloma\",\"therapy\"],\"articleSection\":[\"BioTechnology\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/14\\\/utm_campaignrss-34\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/14\\\/utm_campaignrss-34\\\/\",\"url\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/14\\\/utm_campaignrss-34\\\/\",\"name\":\"FDA clears Bristol a number of myeloma remedy, marking debut of latest drug class - Future News 24\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/14\\\/utm_campaignrss-34\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/14\\\/utm_campaignrss-34\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.statnews.com\\\/wp-content\\\/uploads\\\/2022\\\/12\\\/AdobeStock_251916311-1024x576.jpeg\",\"datePublished\":\"2026-08-14T12:03:00+00:00\",\"dateModified\":\"2026-08-17T00:59:04+00:00\",\"description\":\"Zenbexus, from Bristol Myers Squibb, is also first drug cleared using more sensitive measure of cancer remission.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/14\\\/utm_campaignrss-34\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/14\\\/utm_campaignrss-34\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/14\\\/utm_campaignrss-34\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.statnews.com\\\/wp-content\\\/uploads\\\/2022\\\/12\\\/AdobeStock_251916311-1024x576.jpeg\",\"contentUrl\":\"https:\\\/\\\/www.statnews.com\\\/wp-content\\\/uploads\\\/2022\\\/12\\\/AdobeStock_251916311-1024x576.jpeg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/2026\\\/08\\\/14\\\/utm_campaignrss-34\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/futurenews24.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FDA clears Bristol a number of myeloma remedy, marking debut of latest drug class\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#website\",\"url\":\"https:\\\/\\\/futurenews24.com\\\/\",\"name\":\"Future News 24\",\"description\":\"The Smart Hub for AI and Next-Gen Innovation\",\"publisher\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/futurenews24.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#organization\",\"name\":\"Future News 24\",\"url\":\"https:\\\/\\\/futurenews24.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/futurenews24.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/fn24-favicon.png\",\"contentUrl\":\"https:\\\/\\\/futurenews24.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/fn24-favicon.png\",\"width\":250,\"height\":250,\"caption\":\"Future News 24\"},\"image\":{\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/futurenews24.com\\\/#\\\/schema\\\/person\\\/cecad1bde21cfc357cf70128144d6c83\",\"name\":\"Future News 24\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g\",\"caption\":\"Future News 24\"},\"sameAs\":[\"https:\\\/\\\/futurenews24.com\"],\"url\":\"https:\\\/\\\/futurenews24.com\\\/index.php\\\/author\\\/mridulpahuja20\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FDA clears Bristol a number of myeloma remedy, marking debut of latest drug class - Future News 24","description":"Zenbexus, from Bristol Myers Squibb, is also first drug cleared using more sensitive measure of cancer remission.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/futurenews24.com\/index.php\/2026\/08\/14\/utm_campaignrss-34\/","og_locale":"en_US","og_type":"article","og_title":"FDA clears Bristol a number of myeloma remedy, marking debut of latest drug class - Future News 24","og_description":"Zenbexus, from Bristol Myers Squibb, is also first drug cleared using more sensitive measure of cancer remission.","og_url":"https:\/\/futurenews24.com\/index.php\/2026\/08\/14\/utm_campaignrss-34\/","og_site_name":"Future News 24","article_published_time":"2026-08-14T12:03:00+00:00","article_modified_time":"2026-08-17T00:59:04+00:00","og_image":[{"url":"https:\/\/www.statnews.com\/wp-content\/uploads\/2022\/12\/AdobeStock_251916311-1024x576.jpeg","type":"","width":"","height":""}],"author":"Future News 24","twitter_card":"summary_large_image","twitter_image":"https:\/\/www.statnews.com\/wp-content\/uploads\/2022\/12\/AdobeStock_251916311-1024x576.jpeg","twitter_misc":{"Written by":"Future News 24","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/futurenews24.com\/index.php\/2026\/08\/14\/utm_campaignrss-34\/#article","isPartOf":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/08\/14\/utm_campaignrss-34\/"},"author":{"name":"Future News 24","@id":"https:\/\/futurenews24.com\/#\/schema\/person\/cecad1bde21cfc357cf70128144d6c83"},"headline":"FDA clears Bristol a number of myeloma remedy, marking debut of latest drug class","datePublished":"2026-08-14T12:03:00+00:00","dateModified":"2026-08-17T00:59:04+00:00","mainEntityOfPage":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/08\/14\/utm_campaignrss-34\/"},"wordCount":280,"commentCount":0,"publisher":{"@id":"https:\/\/futurenews24.com\/#organization"},"image":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/08\/14\/utm_campaignrss-34\/#primaryimage"},"thumbnailUrl":"https:\/\/www.statnews.com\/wp-content\/uploads\/2022\/12\/AdobeStock_251916311-1024x576.jpeg","keywords":["Bristol","class","clears","debut","drug","FDA","marking","Multiple","myeloma","therapy"],"articleSection":["BioTechnology"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/futurenews24.com\/index.php\/2026\/08\/14\/utm_campaignrss-34\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/futurenews24.com\/index.php\/2026\/08\/14\/utm_campaignrss-34\/","url":"https:\/\/futurenews24.com\/index.php\/2026\/08\/14\/utm_campaignrss-34\/","name":"FDA clears Bristol a number of myeloma remedy, marking debut of latest drug class - Future News 24","isPartOf":{"@id":"https:\/\/futurenews24.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/08\/14\/utm_campaignrss-34\/#primaryimage"},"image":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/08\/14\/utm_campaignrss-34\/#primaryimage"},"thumbnailUrl":"https:\/\/www.statnews.com\/wp-content\/uploads\/2022\/12\/AdobeStock_251916311-1024x576.jpeg","datePublished":"2026-08-14T12:03:00+00:00","dateModified":"2026-08-17T00:59:04+00:00","description":"Zenbexus, from Bristol Myers Squibb, is also first drug cleared using more sensitive measure of cancer remission.","breadcrumb":{"@id":"https:\/\/futurenews24.com\/index.php\/2026\/08\/14\/utm_campaignrss-34\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/futurenews24.com\/index.php\/2026\/08\/14\/utm_campaignrss-34\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/futurenews24.com\/index.php\/2026\/08\/14\/utm_campaignrss-34\/#primaryimage","url":"https:\/\/www.statnews.com\/wp-content\/uploads\/2022\/12\/AdobeStock_251916311-1024x576.jpeg","contentUrl":"https:\/\/www.statnews.com\/wp-content\/uploads\/2022\/12\/AdobeStock_251916311-1024x576.jpeg"},{"@type":"BreadcrumbList","@id":"https:\/\/futurenews24.com\/index.php\/2026\/08\/14\/utm_campaignrss-34\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/futurenews24.com\/"},{"@type":"ListItem","position":2,"name":"FDA clears Bristol a number of myeloma remedy, marking debut of latest drug class"}]},{"@type":"WebSite","@id":"https:\/\/futurenews24.com\/#website","url":"https:\/\/futurenews24.com\/","name":"Future News 24","description":"The Smart Hub for AI and Next-Gen Innovation","publisher":{"@id":"https:\/\/futurenews24.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/futurenews24.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/futurenews24.com\/#organization","name":"Future News 24","url":"https:\/\/futurenews24.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/futurenews24.com\/#\/schema\/logo\/image\/","url":"https:\/\/futurenews24.com\/wp-content\/uploads\/2026\/06\/fn24-favicon.png","contentUrl":"https:\/\/futurenews24.com\/wp-content\/uploads\/2026\/06\/fn24-favicon.png","width":250,"height":250,"caption":"Future News 24"},"image":{"@id":"https:\/\/futurenews24.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/futurenews24.com\/#\/schema\/person\/cecad1bde21cfc357cf70128144d6c83","name":"Future News 24","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d57f07142d73cb5503ab2446ea7bc9ef3d0a5ba378d64a6157692311e42bf097?s=96&d=mm&r=g","caption":"Future News 24"},"sameAs":["https:\/\/futurenews24.com"],"url":"https:\/\/futurenews24.com\/index.php\/author\/mridulpahuja20\/"}]}},"_links":{"self":[{"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/posts\/3842","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/comments?post=3842"}],"version-history":[{"count":1,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/posts\/3842\/revisions"}],"predecessor-version":[{"id":3843,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/posts\/3842\/revisions\/3843"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/media\/3844"}],"wp:attachment":[{"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/media?parent=3842"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/categories?post=3842"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/futurenews24.com\/index.php\/wp-json\/wp\/v2\/tags?post=3842"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}